The European Rare DIsease Therapeutic Initiative :

A partnership between academic research institutions and pharmaceutical companies to promote therapeutic research on rare diseases

	An easieraccess to compounds developed by pharmaceutical companies to facilitate their pre-clinical evaluation for the treatment of rare diseases
	4 pharmaceutical partners : GSK, Roche, Sanofi-Aventis, Servier.
	10 European academic institutions supporting ERDITI

A call for proposal is opened : it is intended for European academic scientists holding a research project on a rare disease, or a defined group of rare diseases, who would like access to compounds that have been or are being developed by pharmaceutical companies.